These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 24302707)

  • 1. Induced pluripotent stem cells: origins, applications, and future perspectives.
    Zhao J; Jiang WJ; Sun C; Hou CZ; Yang XM; Gao JG
    J Zhejiang Univ Sci B; 2013 Dec; 14(12):1059-69. PubMed ID: 24302707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. iPS cells: a source of cardiac regeneration.
    Yoshida Y; Yamanaka S
    J Mol Cell Cardiol; 2011 Feb; 50(2):327-32. PubMed ID: 21040726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of induced pluripotent stem cells by efficient reprogramming of adult bone marrow cells.
    Kunisato A; Wakatsuki M; Kodama Y; Shinba H; Ishida I; Nagao K
    Stem Cells Dev; 2010 Feb; 19(2):229-38. PubMed ID: 19558219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Technological overview of iPS induction from human adult somatic cells.
    Bayart E; Cohen-Haguenauer O
    Curr Gene Ther; 2013 Apr; 13(2):73-92. PubMed ID: 23320476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of mouse induced pluripotent stem cells from different genetic backgrounds using Sleeping beauty transposon mediated gene transfer.
    Muenthaisong S; Ujhelly O; Polgar Z; Varga E; Ivics Z; Pirity MK; Dinnyes A
    Exp Cell Res; 2012 Nov; 318(19):2482-9. PubMed ID: 22846649
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of stem cells for therapeutic use.
    Rodgerson DO; Harris AG
    Stem Cell Rev Rep; 2011 Nov; 7(4):782-96. PubMed ID: 21365257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methods for iPS cell generation for basic research and clinical applications.
    Mochiduki Y; Okita K
    Biotechnol J; 2012 Jun; 7(6):789-97. PubMed ID: 22378737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reprogramming therapeutics: iPS cell prospects for neurodegenerative disease.
    Abeliovich A; Doege CA
    Neuron; 2009 Feb; 61(3):337-9. PubMed ID: 19217371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effective culture conditions for the induction of pluripotent stem cells.
    Okada M; Oka M; Yoneda Y
    Biochim Biophys Acta; 2010 Sep; 1800(9):956-63. PubMed ID: 20417254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential application of induced pluripotent stem cells in cell replacement therapy for Parkinson's disease.
    Chen LW; Kuang F; Wei LC; Ding YX; Yung KK; Chan YS
    CNS Neurol Disord Drug Targets; 2011 Jun; 10(4):449-58. PubMed ID: 21495962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Induced Pluripotent Stem Cells in the Curative Treatment of Diabetes and Potential Impediments Ahead.
    Dadheech N; James Shapiro AM
    Adv Exp Med Biol; 2019; 1144():25-35. PubMed ID: 30569414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Embryonic stem cells and iPS cells: sources and characteristics.
    Hackett CH; Fortier LA
    Vet Clin North Am Equine Pract; 2011 Aug; 27(2):233-42. PubMed ID: 21872756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homologous recombination in human iPS and ES cells for use in gene correction therapy.
    Nakayama M
    Drug Discov Today; 2010 Mar; 15(5-6):198-202. PubMed ID: 20116450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induced pluripotent stem cells and their potential for basic and clinical sciences.
    Ye L; Swingen C; Zhang J
    Curr Cardiol Rev; 2013 Feb; 9(1):63-72. PubMed ID: 22935022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gingival fibroblasts as a promising source of induced pluripotent stem cells.
    Egusa H; Okita K; Kayashima H; Yu G; Fukuyasu S; Saeki M; Matsumoto T; Yamanaka S; Yatani H
    PLoS One; 2010 Sep; 5(9):e12743. PubMed ID: 20856871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of pluripotent stem cells from fibroblast cultures.
    Takahashi K; Okita K; Nakagawa M; Yamanaka S
    Nat Protoc; 2007; 2(12):3081-9. PubMed ID: 18079707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical potential of human-induced pluripotent stem cells : Perspectives of induced pluripotent stem cells.
    Kumar D; Anand T; Kues WA
    Cell Biol Toxicol; 2017 Apr; 33(2):99-112. PubMed ID: 27900567
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ES and iPS cell research for cardiovascular regeneration.
    Yamashita JK
    Exp Cell Res; 2010 Oct; 316(16):2555-9. PubMed ID: 20385126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and comparison of osteoblasts derived from mouse embryonic stem cells and induced pluripotent stem cells.
    Ma MS; Kannan V; de Vries AE; Czepiel M; Wesseling EM; Balasubramaniyan V; Kuijer R; Vissink A; Copray SCVM; Raghoebar GM
    J Bone Miner Metab; 2017 Jan; 35(1):21-30. PubMed ID: 26747612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Induction and characterization of induced pluripotent stem (iPS) cells: a review].
    Cheng D; Lei L; Lu Z; Li Z; Wang H
    Sheng Wu Gong Cheng Xue Bao; 2010 Apr; 26(4):421-30. PubMed ID: 20575428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.